Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dmytro Rudoy
Institution:
Fred Hutch Cancer Center
Observed institution:
Fred Hutch Cancer Center
ORCID:
0009-0000-5676-3355
Observed ORCID:
0009-0000-5676-3355
OpenAlex ID:
A5013382657
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
2023
·
Vipul Bhatia
, Nikhil V. Kamat
, et al.
·
Nature Communications
·
154
PDF
SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer
2023
·
Sheng-You Liao
, Dmytro Rudoy
, et al.
·
Nature Communications
·
22
PDF
ERK signaling promotes resistance to TRK kinase inhibition in NTRK fusion-driven glioma mouse models
2024
·
Sebastian Schmid
, Zachary R. Russell
, et al.
·
Cell Reports
·
10
Aggressive high-grade NF2 mutant meningiomas downregulate oncogenic YAP signaling via the upregulation of VGLL4 and FAT3/4
2024
·
Abigail G Parrish
, Sonali Arora
, et al.
·
Neuro-Oncology Advances
·
7
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
2024
·
Sander Frank
, Thomas Persse
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
5
PDF
Therapeutic targeting of the eIF4E cap-binding domain reveals control of lineage fate in prostate cancer
2026
·
Rashmi Mishra
, Sihyeon Song
, et al.
·
Journal of Clinical Investigation
·
4
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
2025
·
Sander Frank
, Thomas Persse
, et al.
·
eLife
·
4
PDF
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
2025
·
Sander Frank
, Thomas Persse
, et al.
·
eLife
·
3
tRNA dosage regulates lineage dependency and resistance in prostate cancer
2026
·
Yeon Soo Kim
, Sonali Arora
, et al.
·
Nature
·
2
PDF
Evolution and heterogeneity of lethal metastatic bladder cancer subtypes
2026
·
Pushpa Itagi
, Samantha L. Schuster
, et al.
·
Nature
·
2
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
2024
·
Sander Frank
, Thomas Persse
, et al.
·
eLife
·
2
Lethal giant larvae gene family ( Llgl1 and Llgl2 ) functions as a tumor suppressor in mouse skin epidermis
2023
·
Victor M. Bii
, Dmytro Rudoy
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell therapy
2022
·
Vipul Bhatia
, Nikhil V. Kamat
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
Data from SPEN Inactivation Drives Resistance to Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer
2026
·
Steven Blinka
, Sonali Arora
, et al.
Supplementary Data 5 from SPEN Inactivation Drives Resistance to Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer
2026
·
Steven Blinka
, Sonali Arora
, et al.
Supplementary Data 4 from SPEN Inactivation Drives Resistance to Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer
2026
·
Steven Blinka
, Sonali Arora
, et al.
Supplementary Data 2 from SPEN Inactivation Drives Resistance to Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer
2026
·
Steven Blinka
, Sonali Arora
, et al.
Supplementary Data 6 from SPEN Inactivation Drives Resistance to Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer
2026
·
Steven Blinka
, Sonali Arora
, et al.
Supplementary Data 1 from SPEN Inactivation Drives Resistance to Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer
2026
·
Steven Blinka
, Sonali Arora
, et al.
Supplementary Data 3 from SPEN Inactivation Drives Resistance to Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer
2026
·
Steven Blinka
, Sonali Arora
, et al.
SPEN Inactivation Drives Resistance to Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer
2026
·
Steven Blinka
, Sonali Arora
, et al.
·
Clinical Cancer Research
PDF
Abstract PR032: Therapeutic targeting of eIF4E cap-binding domain reveals control of lineage fate in prostate cancer
2026
·
Rashmi Mishra
, Sihyeon Song
, et al.
·
Cancer Research
Author response: Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
2025
·
Sander Frank
, Thomas Persse
, et al.
·
eLife
Csig-08. Aggressive High-grade Nf2 Mutant Meningiomas Downregulate Oncogenic Yap Signaling Via the Upregulation of Vgll4 and Fat3/4
2024
·
Abigail Parrish
, Sonali Arora
, et al.
·
Neuro-Oncology
PDF
Abstract B060: Characterization of DNA repair defects in CDK12 mutant prostate cancer and the identification of differential vulnerabilities
2023
·
Sander Frank
, Ilsa Coleman
, et al.
·
Cancer Research
Show more works
View as search
Works count:
26
Citation count:
218
H-index:
5
I10-index:
3
Year
Topic
Type